Skip to main content
Top
Literature
1.
go back to reference Wang X, Xie T, Luo J, Zhou Z, Yu X, Guo X. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res BCR. 2022;24(1):20.CrossRef Wang X, Xie T, Luo J, Zhou Z, Yu X, Guo X. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res BCR. 2022;24(1):20.CrossRef
3.
go back to reference Tomaszewski M, Gillies R. The biological meaning of radiomic features. Radiology. 2021;299(2):E256.CrossRef Tomaszewski M, Gillies R. The biological meaning of radiomic features. Radiology. 2021;299(2):E256.CrossRef
4.
go back to reference Vitale I, Manic G, Coussens L, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36–50.CrossRef Vitale I, Manic G, Coussens L, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36–50.CrossRef
5.
go back to reference Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett. 2013;332(1):3–10.CrossRef Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett. 2013;332(1):3–10.CrossRef
6.
go back to reference Blessin N, Li W, Mandelkow T, Jansen H, Yang C, Raedler J, Simon R, Büscheck F, Dum D, Luebke A, et al. Prognostic role of proliferating CD8 cytotoxic Tcells in human cancers. Cell Oncol (Dordr). 2021;44(4):793–803.CrossRef Blessin N, Li W, Mandelkow T, Jansen H, Yang C, Raedler J, Simon R, Büscheck F, Dum D, Luebke A, et al. Prognostic role of proliferating CD8 cytotoxic Tcells in human cancers. Cell Oncol (Dordr). 2021;44(4):793–803.CrossRef
7.
go back to reference Ahmadvand S, Faghih Z, Montazer M, Safaei A, Mokhtari M, Jafari P, Talei A, Tahmasebi S, Ghaderi A. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Cell Oncol (Dordr). 2019;42(3):343–56.CrossRef Ahmadvand S, Faghih Z, Montazer M, Safaei A, Mokhtari M, Jafari P, Talei A, Tahmasebi S, Ghaderi A. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Cell Oncol (Dordr). 2019;42(3):343–56.CrossRef
8.
go back to reference Qiu S, Waaijer S, Zwager M, de Vries E, van der Vegt B, Schröder C. Tumor-associated macrophages in breast cancer: Innocent bystander or important player? Cancer Treat Rev. 2018;70:178–89.CrossRef Qiu S, Waaijer S, Zwager M, de Vries E, van der Vegt B, Schröder C. Tumor-associated macrophages in breast cancer: Innocent bystander or important player? Cancer Treat Rev. 2018;70:178–89.CrossRef
Metadata
Title
Biological interpretation of prognostic radiomic score by correlating with tumor heterogeneity and microenvironment
Authors
Jieling Zheng
Bin Zhang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2022
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/s13058-022-01527-x

Other articles of this Issue 1/2022

Breast Cancer Research 1/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine